For laboratory research use only. Not for human or animal use or consumption.
CJC-1295 + Ipamorelin white carton and sachet
ADVNC STRIPS / PRODUCT INFORMATION

CJC-1295 + Ipamorelin

For laboratory research use only. Not for human or animal use or consumption.

250 mcg CJC-1295 · 250 mcg Ipamorelin / film — content specification reference, not an analytical result.

Unavailable
1

FOR RESEARCH USE ONLY
Not for human or animal use or consumption.

Film composition and material records

Content per film is shown as a product specification reference. It does not establish production release or analytical results; see Batch documents for applicable records.

Reference content / film
250 mcg CJC-1295 · 250 mcg Ipamorelin
Supporting ingredients
Pullulan, Stevia Glycosides, Hydroxypropyl Methylcellulose (HPMC), Vegetable Glycerin, Citric Acid, Xanthan Gum, Sunflower Lecithin, Gum Arabic.
Historical format
20 films per box. This is a historical format reference, not an approved RUO count.

Batch documents

No batch reports are published for this formulation.

Historical internal QA documents

Original supplied PDFs are preserved. These summaries list input-based active values, raw-material HPLC entries, and named screening methods; underlying laboratory reports and independent verification were not supplied. They do not establish the current RUO specifications.

CJC-1295 + Ipamorelin L1432Internal QA summary · Document available
Scope
Historical internal QA record, lot L1432. CJC-1295 + Ipamorelin oral film: active content by input, raw-material purity by HPLC, heavy metals (USP 233), microbials (USP 2021/2022).
Issuer
Quality Assurance / VP of Quality sign-offs; legal issuer not identified.
Laboratory
Not identified in source; underlying analytical reports not supplied.
Report date / identifier
2026-08-17 / ST00371
Interpretation
By-Input is not a finished-film content assay. Raw-material HPLC values are not finished-film purity. No issuer verification destination is supplied.
Internal QA summary (PDF) ↗

Published research

Selected constituent studies describe their actual preparations and experimental systems. None evaluated ADVNC Strips or establish finished-film performance.

CJC-1295

PRIMARY STUDY · CJC-1295 · Human

Long-acting CJC-1295: pharmacokinetic study

Teichman et al. · Journal of Clinical Endocrinology & Metabolism 91(3):799–805 · 2006

Preparation
Two randomized, placebo-controlled studies in healthy adults; investigational subcutaneous formulation
Research question
What pharmacokinetic and endocrine measurements characterize the long-acting construct?
Measurements
Pharmacokinetic and endocrine measurements of long-acting CJC-1295.
Scope & limits
Not unspecified or no-DAC material; no ipamorelin combination or ADVNC film inference.
Original publication

DOI 10.1210/jc.2005-1536 · PMID 16352683

Ipamorelin

PRIMARY STUDY · Ipamorelin · Cell / ex vivo; animal

Cell and animal pharmacology models

Raun et al. · European Journal of Endocrinology 139(5):552–561 · 1998

Preparation
Primary rat pituitary cells, rats, and swine
Research question
How is ipamorelin characterized in cellular and animal pharmacology systems?
Measurements
Cellular and animal pharmacology responses, including endocrine measurements.
Scope & limits
Constituent research; no CJC-1295 combination or ADVNC film evaluation.
Original publication

DOI 10.1530/eje.0.1390552 · PMID 9849822

Material information

The carton and sachet images show supplied packaging artwork. No applicable approved handling, storage, shelf-life, or stability specification has been supplied. Historical QA storage wording is not transferred to this formulation.

References by document type

Internal QA / analytical documents

Literature

Original publications are linked individually in Published research.

Reading study scope →